Proteins

Product description：GSK-3β inhibitor.

Product description：GSK-3β inhibitor.

Potent α2β1inhibitor: displays antithrombotic activityin vivo.

Potent α2β1inhibitor: displays antithrombotic activityin vivo.

Product descriptionLck Inhibitor is a potent, orally active Lck (lymphocyte specific kinase) inhibitor with IC50s of 7, 2.1, 4.2 and 200 nM for Lck, Lyn, Src and Syk kinases, respectively. Lck Inhibitor shows &gt:1000-fold selectivity for Lck over

Product descriptionLck Inhibitor is a potent, orally active Lck (lymphocyte specific kinase) inhibitor with IC50s of 7, 2.1, 4.2 and 200 nM for Lck, Lyn, Src and Syk kinases, respectively. Lck Inhibitor shows &gt:1000-fold selectivity for Lck over

Product descriptionLck Inhibitor is a potent, orally active Lck (lymphocyte specific kinase) inhibitor with IC50s of 7, 2.1, 4.2 and 200 nM for Lck, Lyn, Src and Syk kinases, respectively. Lck Inhibitor shows &gt:1000-fold selectivity for Lck over

Product descriptionLck Inhibitor is a potent, orally active Lck (lymphocyte specific kinase) inhibitor with IC50s of 7, 2.1, 4.2 and 200 nM for Lck, Lyn, Src and Syk kinases, respectively. Lck Inhibitor shows &gt:1000-fold selectivity for Lck over

Product descriptionLck Inhibitor is a potent, orally active Lck (lymphocyte specific kinase) inhibitor with IC50s of 7, 2.1, 4.2 and 200 nM for Lck, Lyn, Src and Syk kinases, respectively. Lck Inhibitor shows &gt:1000-fold selectivity for Lck over

Potent and selective DYRK1A/B inhibitor.

Potent and selective DYRK1A/B inhibitor.

Potent and selective PLK2 inhibitor.